XERS R&D Expenses
Xeris Biopharma Holdings Inc · R&D Expenses
XERS R&D Expenses
Latest reported$10.67Mperiod ending
XERS Quarterly R&D Expenses ($3.66M → $10.67M)
Quarterly R&D Expenses
High-resolution chart · PNG
XERS r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 10,669,000 | |
| 8,783,000 | |
| 7,874,000 | |
| 7,483,000 | |
| 8,055,000 | |
| 7,753,000 | |
| 6,092,000 | |
| 5,888,000 | |
| 5,759,000 | |
| 7,821,000 | |
| 6,382,000 | |
| 5,034,000 | |
| 6,087,000 | |
| 4,838,000 | |
| 4,955,000 | |
| 6,043,000 | |
| 3,718,000 | |
| 6,250,000 | |
| 10,082,000 | |
| 5,663,000 | |
| 5,383,000 | |
| 4,032,000 | |
| 5,110,000 | |
| 3,876,000 | |
| 5,289,000 | |
| 6,646,000 | |
| 12,420,000 | |
| 15,518,000 | |
| 19,333,000 | |
| 13,167,000 | |
| 12,390,000 | |
| 10,875,000 | |
| 8,677,000 | |
| 8,712,000 | |
| 6,578,000 | |
| 5,725,000 | |
| 4,201,000 | |
| 3,662,000 |